Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin effects on cycling performance
NL-OMON21046Not yet recruiting
- Sponsor
- Internal
- Start
- Jan 2016
- Modality
- Small Molecules, Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of epoetin beta and ascorbic acid, sponsored by Internal. Primary endpoints: Oxygen consumption, Carbon dioxide production and 22 more. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
epoetin betaascorbic acid
Beyond the preview
Go deeper on NL-OMON21046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21046.